Skip to content
Recall Observatory FDA recall evidence

Drug product

PF-Labetalol HCl Injection, USP, 20 mg/4 mL (5 mg/mL), One 4 mL Unit-Dose Vial, packaged in 30 x 4 mL Sterile Unit-dose Vials per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th Street Extension, West Columbia, SC 29172; NDC 69374-946-34

D-1347-2022

August 10, 2022

Class II

Product summary

Firm
Nephron Sterile Compounding Center LLC
Event
Event 90718
Status
Terminated
Classification
Class II
Quantity
33,870 vials
Official record key
drug-enforcement:D-1347-2022

Official wording

Reason: CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Code information: Lot: LB2005A, Exp 3/2/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations